Putnam Investments’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.2M Buy
33,708
+6,196
+23% +$230K ﹤0.01% 823
2023
Q3
$1.21M Sell
27,512
-234
-0.8% -$11.4K ﹤0.01% 812
2023
Q2
$1.37M Buy
27,746
+16,837
+154% +$776K ﹤0.01% 806
2023
Q1
$452K Sell
10,909
-104,127
-91% -$4.32M ﹤0.01% 961
2022
Q4
$5.11M Buy
115,036
+25,221
+28% +$1.05M 0.01% 431
2022
Q3
$3.51M Sell
89,815
-615
-0.7% -$28.1K 0.01% 537
2022
Q2
$3.69M Buy
90,430
+2,179
+2% +$103K 0.01% 537
2022
Q1
$5.8M Buy
88,251
+627
+0.7% +$40.6K 0.01% 462
2021
Q4
$6.09M Buy
87,624
+21,055
+32% +$1.53M 0.01% 483
2021
Q3
$4.63M Buy
66,569
+9,338
+16% +$719K 0.01% 546
2021
Q2
$4.54M Buy
+57,231
New +$4.16M 0.01% 535
2016
Q2
Sell
-62,367
Closed -$1.05M 1334
2016
Q1
$1.05M Buy
62,367
+1,232
+2% +$21.7K ﹤0.01% 1104
2015
Q4
$1.37M Sell
61,135
-797
-1% -$16.4K ﹤0.01% 1070
2015
Q3
$1.36M Buy
61,932
+1,835
+3% +$45.9K ﹤0.01% 1092
2015
Q2
$1.48M Sell
60,097
-282
-0.5% -$6.3K ﹤0.01% 1136
2015
Q1
$1.24M Sell
60,379
-319,832
-84% -$6.2M ﹤0.01% 1161
2014
Q4
$7.59M Buy
380,211
+2,871
+0.8% +$49.3K 0.02% 609
2014
Q3
$5.55M Buy
377,340
+9,867
+3% +$157K 0.01% 727
2014
Q2
$6.75M Sell
367,473
-180
-0% -$3K 0.01% 654
2014
Q1
$6.92M Buy
+367,653
New +$7.53M 0.02% 620

Other funds holding ATRC

Putnam Investments's ATRC Position: Q4 2023 in Review

Putnam Investments increased its AtriCure (ATRC) stake by 23% in Q4 2023, buying an estimated $230K and bringing the position to 33,708 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Putnam Investments first reported a position in ATRC in Q1 2014 and has held it in 20 quarters since. The position peaked at $7.59M in Q4 2014. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Putnam Investments held 33,708 shares of AtriCure worth $1.2M as of Q4 2023.
  • Putnam Investments bought 6,196 AtriCure shares in Q4 2023, an estimated $230K.
  • AtriCure made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #823 holding.
  • Putnam Investments first reported a position in AtriCure in Q1 2014 and has held it in 20 quarters since.
  • Putnam Investments's AtriCure position peaked at $7.59M in Q4 2014.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.